Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Chinese Journal of Industrial Hygiene and Occupational Diseases ; (12): 661-666, 2012.
Article in Chinese | WPRIM | ID: wpr-242768

ABSTRACT

<p><b>OBJECTIVE</b>To discuss the urine biomarkers in 1,3-butadiene exposed workers, and to provide basement for establishing biological limit value.</p><p><b>METHODS</b>44 BD exposed workers as exposure group and 25 BD non-exposed people as control group including 12 workers in boiler workshop in the same factory and 13 people in one public institute, we collected their in-end-of shift urine, then detected urine BD-derived mercapturic metabolites [3,4-dihydroxybutyl mercapturic acid (DHBMA),1- and 2-monohydroxy-3-butenyl mercapturic acid (MHBMA)] concentrations using UPLC-MS/MS method. Meanwhile, we detected air BD concentration with GC-FID in the workplace, and compared their relationship.</p><p><b>RESULTS</b>lgDHBMA and lg (MHBMA + DHBMA) levels in exposed group (lgDHBMA: 2.51 ± 0.44) µg/L, lg [MHBMA + DHBMA: (2.68 ± 0.27) µg/L] were higher than which in control group (lgDHBMA: (2.20 ± 0.25) µg/L, lg(MHBMA + DHBMA: (2.49 ± 0.34) µg/L), and the differences were significant (P < 0.01). Urine DHBMA was obviously influenced by air BD concentrations (r = 0.539, P = 0.001). The equation of Multiple Regression Analysis was y = 2.417 + 0.520x (x represents air BD dose, and represents urinary DHBMA level). Adjusted R(2) of this model was 0.262. Urinary MHBMA was not affected by smoking, alcohol and years of works.</p><p><b>CONCLUSION</b>Urine metabolite DHBMA in BD-exposed workers might be major biological exposure indice.</p>


Subject(s)
Adult , Female , Humans , Male , Middle Aged , Biomarkers , Urine , Butadienes , Occupational Exposure , Surveys and Questionnaires
2.
Journal of Central South University(Medical Sciences) ; (12): 312-315, 2008.
Article in Chinese | WPRIM | ID: wpr-814078

ABSTRACT

OBJECTIVE@#To determine whether antipsychotic agent-induced weight gain was associated with 5-hydroxytryptamine 2C receptor (HTR2C) gene-759C/T and -697G/C polymorphisms.@*METHODS@#A case-matching controlled study was done. Eighty-five patients who had gained more than 7% of their pre-drug body weight served as a study group, and 85 patients who had gained less than 7% of their pre-drug body weight served as a control group. The control group were matched with the study group in the kinds of antipsychotic agents and the course of antipsychotic treatment. The ligation diction reaction technique was used to analyse the frequencies of HTR2C gene-759C/T and -697G/C polymorphisms.@*RESULTS@#The study group were more likely to be hemizygous for the -759C (for male) and the -759CC genotype (for female) than the control group. The study group were more likely to be hemizygous for the -697G (for male) and the -697CG/GG genotype (for female) (all P<0.05) than the control group.@*CONCLUSION@#The -759C/T and -697G/C polymorphisms of the promoter region of HTR2C gene may be associated with antipsychotic agent-induced weight gain.


Subject(s)
Adolescent , Adult , Female , Humans , Male , Antipsychotic Agents , Therapeutic Uses , Case-Control Studies , Genotype , Polymorphism, Genetic , Promoter Regions, Genetic , Genetics , Receptor, Serotonin, 5-HT2C , Genetics , Schizophrenia , Drug Therapy , Genetics , Weight Gain , Genetics
SELECTION OF CITATIONS
SEARCH DETAIL